Novartis India (NSE:NOVARTIND, BOM:500672) said its net profit fell to 254.5 million Indian rupees in the fiscal third quarter from 265.7 million rupees a year ago, according to a filing to the stock exchanges on Tuesday.
Earnings per share for the quarter ended Dec. 31, 2024, dropped to 10.31 rupees from 10.76 rupees a year earlier.
Revenue from operations of the pharmaceutical company increased year on year to 930 million rupees from 845.4 million rupees, according to the filing.
Price (INR): ₹674.00, Change: ₹+1.8, Percent Change: +0.26%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.